GlassScriptPhysician profile
Joseph D Rich
NPI 1952666919
$7,713.57
in general payments reported to CMS, 2019-2025
18 companies · $2,157 in 2025
The $2,157 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,195 · 2020: $451 · 2021: $363 · 2022: $534 · 2023: $878 · 2024: $1,137 · 2025: $2,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Entertainment: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,303.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Entertainment | $368.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,740.94 | 2019-2025 | Precision 1, Air Optix Color, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,131.85 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $545.55 | 2022-2025 | Infuse |
| Optos, INC. | $368.17 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $355.83 | 2024-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $276.65 | 2022-2025 | Acuvue |
| Allergan, INC. | $238.25 | 2019-2021 | |
| Glaukos Corporation | $237.81 | 2022 | |
| Lkc Technologies, INC. | $163.54 | 2025 | |
| Lumenis Be INC | $141.11 | 2023 | M22 |
| Dompe US, INC. | $134.56 | 2023 | Oxervate |
| Maculogix, INC. | $89.69 | 2019 | |
| Apellis Pharmaceuticals, INC. | $89.33 | 2024 | Syfovre |
| Menicon America INC | $65.98 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $55.95 | 2022-2024 | Contact Lens, Spectacle Lenses |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $33.68 | 2022-2023 | Tearcare System |
| Mallinckrodt Hospital Products INC. | $24.51 | 2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $20.17 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.